|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
Agents identified as
cholesterol inhibitors are useful in preventing and treating cardiovascular
and neurodegenerative diseases associated with over accumulation of
cholesterol in cells. These agents are expected to slow the development of
atherosclerosis and the accumulation of amyloid beta-peptides in the brain,
thereby slowing down the symptoms of Alzheimer’s disease. Therefore, methods for detecting and
monitoring cellular cholesterol is of critical importance to human health. Since BCθ signal can be
monitored using fluorescence instead of radioactivity, the use of BCθ in
combination with 25RA and CT43 cells is well-suited for high-throughput rapid
screening for compounds that interfere with cholesterol accumulation after
loading with LDL. These findings are claimed in
the issued United States Patent Nos. 7,186,519 and 7,361,482. We are seeking an industrial partner who is
interested in the commercialization of this technology. (Ref: J215) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
11 Rope Ferry Road #6210 |
||||
|
Hanover, NH 03755-1404 |
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|